UK Plans Brain Cancer Review and National Lead After Swimmer's TV Plea

Archie Goodburn is a 25-year-old Scottish swimmer with inoperable brain cancer. He went on BBC Breakfast and asked the Prime Minister for help. He was later invited to Downing Street, and the UK government announced four steps aimed at speeding up brain cancer research and care.¹²

The steps are commitments and reviews, not finished results. No new funding was announced. But they include one of Goodburn’s key requests: a national brain cancer lead.¹⁴

The appeal

On BBC Breakfast, Goodburn asked the government to appoint a national lead for brain cancer and to improve access to clinical trials. He pointed out that some trials open to patients in the US, Australia and China are not available to people in the UK.²

“Please establish a national brain cancer lead and give us a chance to fight for our lives”

That is how Joe.co.uk quoted his plea.²

Goodburn was diagnosed with three inoperable oligodendrogliomas, a type of brain tumor, while training for the 2024 Olympic trials. He has had chemotherapy and radiotherapy and has kept competing, including at the Commonwealth Games in Glasgow.²⁴

After the broadcast, Prime Minister Andy Burnham contacted him and invited him to Downing Street. Goodburn met Burnham and Health Secretary Yvette Cooper there on Oct. 14, 2026.¹²

The four steps

According to the Prime Minister’s Office announcement, the government will:¹³

• Start an expert review right away. Prof. Anthony Chalmers will lead it, and it is due to report within three months.
• Follow up with a national action plan built on that review.
• Appoint a national brain cancer clinical lead. The Department of Health and Social Care will make the appointment, which the government says will be announced “in due course.”
• Ask regulators to move faster. The Medicines and Healthcare products Regulatory Agency (MHRA), the UK’s medicines regulator, is reviewing the rules for orphan drugs, which are medicines for rare diseases. The government has asked it to finish in two years instead of three.

The Chalmers review will look at what has changed for patients since a 2018 government review of brain tumor research, and what is still holding progress back. Its findings will go to the All-Party Parliamentary Group on Brain Tumours and to brain cancer charities.¹

The orphan drug review is required by the Rare Cancers Act 2026.¹

Getting more patients into trials

Clinical trials, the studies that test new treatments on patients, were central to Goodburn’s appeal. Cooper will host a roundtable with researchers, doctors and charities to look for ways to get more people into them. Next year, her department plans to work with Cancer Research UK to bring together brain cancer experts from around the world.¹³

The government also noted work already underway. The National Institute for Health and Care Research (NIHR) is supporting 59 brain tumor studies, including 35 clinical trials. In January 2026, the government announced £25 million for the NIHR Brain Tumour Research Consortium.¹

What people said

“Archie is an inspiration to us all, and I am determined to deliver the change patients and their families deserve,” Burnham said in the government’s announcement. He added: “Families facing this disease can’t afford to wait.”¹

Cooper said in the same release that “Archie has shown extraordinary courage in speaking out and fighting for everyone affected by brain cancer.”¹

Goodburn himself was measured. He said Burnham and Cooper addressed all of his policy requests “to some extent,” according to SwimSwam.⁴

Brain tumor charities, including Brainstrust, Brain Tumour Research, Brain Tumour Support, The Brain Tumour Charity and the Tessa Jowell Foundation, welcomed the announcement, as did Cancer Research UK.¹

The next marker is the Chalmers review, due within three months, and the name of the person who will hold the job Goodburn asked for on television.